Sector consensus WuXi Biologics (Cayman) Inc. OTC Markets
Stocks
WXXW.Y
US98260N1081
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.550 USD | -0.66% |
|
-8.04% | -5.62% |
| Jun. 05 | Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub | CI |
| May. 31 | Wuxi Biologics adds 69 projects in Jan-April, maintains expected revenue growth | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 846.68 | +11.7% | 15 | ||||||
| 145.96 | +56.14% | 16 | ||||||
| 106.48 | +43.1% | 19 | ||||||
| 199 | +100.93% | 21 | ||||||
| 2,313.13 | +43.63% | 15 | ||||||
| 49.65 | -6.31% | 17 | ||||||
| 547.64 | +41.36% | 17 | ||||||
| 21.27 | +99.12% | 13 | ||||||
| 810.5 | -18.13% | 6 | ||||||
| 148.87 | +92.53% | 20 | ||||||
| 679.29 | +42.44% | 14 | ||||||
| 88.17 | +20.23% | 12 | ||||||
| 104.7 | +52.96% | 20 | ||||||
| 13 | +79.31% | 3 | ||||||
| 138.77 | +12.59% | 18 | ||||||
| 414.05 | -0.55% | 20 | ||||||
| 100.61 | +68.35% | 15 | ||||||
| - | - | - | - | - | - | |||
| Average | 395.75 | +43.49% | 15 | ||||||
| Weighted average by Cap. | 461.06 | +41.40% | 16 |
Select your edition
All financial news and data tailored to specific country editions
